Patrice Milos

Dr. Milos, a pioneer at the interface of genomics and medicine, joined Claritas Genomics to realize the power of combining next-generation DNA sequencing technology with the clinical expertise of the world’s best pediatric specialists to inform and improve patient care. Previously, Patrice served as the Boston Site Head for Pfizer’s Centers of Therapeutic Innovation and Precision Medicine Lead, establishing academic medical center partnerships, including Beth Israel, Boston Children’s Hospital, Tufts Medical Center, Boston University School of Medicine and Partners Healthcare, to establish proof of mechanism for novel targets and pathways aiming to treat human disease. Dr. Milos previously served as the Senior Vice President and Chief Scientific Officer for Helicos BioSciences, Cambridge, MA. Her expertise and extensive knowledge in the life sciences helped advance the company’s efforts to develop and apply innovative and breakthrough single molecule DNA and RNA sequencing technology with recent focus on molecular diagnostics. Accomplishments included the development of the world’s first and only method for direct capture and sequencing of BRCA1/2, the only method for direct sequencing of RNA and collaborations with institutions including the Broad Institute, Harvard Medical School, Massachusetts General Hospital and the Children’s Oncology Group. Patrice previously served as Executive Director for Pfizer Global Research and Development with responsibilities for leadership of pharmacogenomics, proteomics, metabonomics, DNA sequencing, RNA profiling, and translational biomarkers applied across the Pfizer portfolio from early discovery into the marketplace.

Dr. Milos serves on the Boston Children’s Hospital Technology Advisory Board, is an active NIH grant reviewer and has served on the National Advisory Council for Human Genome Research. Patrice was also pivotal in the establishment and oversight of key Pfizer strategic investments in the genomics area, most notably, the Genetic Association Information Network in partnership with NIH. She also sits on several journal editorial boards and has published and presented extensively in genomic sciences. Dr. Milos conducted post-doctoral fellowships at Brown University and Harvard University. She earned her MS and PhD degrees at Rensselaer Polytechnic Institute in Troy, NY.